RBC Capital raises Kymera Therapeutics price target on pipeline
RBC Capital raises Kymera Therapeutics price target on pipeline progress
Chord Energy 2026 slides: FCF growth targets 40% on efficiency gains
All eyes on Rocket earnings: Can acquisitions drive growth?
Newsletter
Subscribe to get the latest news, offers and special announcements.


